Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Phenotypes and Treatment Pathways in Primary Sjogren's Syndrome: an International Cross-sectional Survey of Rheumatologists and Adult Primary Sjögren's Syndrome Patients With Systemic Involvement (Adelphi 2018 pSS Disease Specific Programme)

NCT03501420 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03501420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03501420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Phenotypes and Treatment Pathways in Primary Sjogren's Syndrome: an International Cross-sectional Survey of Rheumatologists and Adult Primary Sjögren's Syndrome Patients With Systemic Involvement (Adelphi 2018 pSS Disease Specific Programme)
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
June 13, 2018
Completion date
October 30, 2018
Enrollment
2,223 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sjogren's syndrome